| TGFβ pathway inhibition in the treatment of non-small cell lung cancer PÖ Eser, PA Jänne Pharmacology & therapeutics 184, 112-130, 2018 | 99 | 2018 |
| Marine-and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation PO Eser, JP Vanden Heuvel, J Araujo, JT Thompson Molecular and clinical oncology 1 (3), 444-452, 2013 | 47 | 2013 |
| EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody–Drug Conjugate HER3–DXd HM Haikala, T Lopez, J Köhler, PO Eser, M Xu, Q Zeng, TJ Teceno, K Ngo, ... Cancer research 82 (1), 130-141, 2022 | 33 | 2022 |
| Activation of tumor-cell STING primes NK-cell therapy EH Knelson, EV Ivanova, M Tarannum, M Campisi, PH Lizotte, MA Booker, ... Cancer immunology research 10 (8), 947-961, 2022 | 28 | 2022 |
| A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non–Small Cell Lung Cancer J Son, J Jang, TS Beyett, Y Eum, HM Haikala, A Verano, M Lin, ... Cancer research 82 (8), 1633-1645, 2022 | 20 | 2022 |
| Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer PÖ Eser, RM Paranal, J Son, E Ivanova, Y Kuang, HM Haikala, C To, ... Science translational medicine 13 (609), eabb3738, 2021 | 14 | 2021 |
| 10e12z CLA alters adipocyte differentiation and adipocyte cytokine expression and induces macrophage proliferation BJ Belda, JT Thompson, PO Eser, JPV Heuvel The Journal of nutritional biochemistry 23 (5), 510-518, 2012 | 13 | 2012 |
| EGFR inhibition enhances the cellular uptake and antitumor activity of the novel HER3 antibody drug conjugate U3-1402 HM Haikala, J Köhler, T Lopez, P Eser, M Xu, C Yu, Y Shiose, Y Qiu, ... Cancer Research 80 (16_Supplement), 5192-5192, 2020 | 6 | 2020 |
| Switch to MET oncogene dependence as a novel mechanism of drug resistance in EGFR-mutant lung cancer PÖ Eser, RM Paranal, MJ Poitras, M Xu, S Wang, A Ogino, J Choi, ... Cancer Research 79 (13_Supplement), 1732-1732, 2019 | 2 | 2019 |
| Genome-scale CRISPR screen finds prostate lineage specific dependencies A Attari, S Misek, P Eser, A Yeagley, Y Chen, J Boehm, YY Tseng Cancer Research 81 (13_Supplement), 2975-2975, 2021 | | 2021 |
| Abstract PO-093: Evaluating dependencies by rapid image-based ex vivo cancer biosensors M Al-Jazrawe, C Molnar, N Rindtorff, P Eser, S Misek, M Alimova, O Ursu, ... Clinical Cancer Research 27 (5_Supplement), PO-093-PO-093, 2021 | | 2021 |
| Bridging the Divide: Student Grand Rounds at the Interface of Basic Science and Clinical Medicine MA Hollenhorst, DA Braun, CR Burtner, I Cajigas, ... Academic Medicine 95 (4), 548-552, 2020 | | 2020 |
| Characterizing resistance and sensitivity to targeted therapies in patient-derived models of EGFR mutant lung cancer PO Eser Harvard University, 2018 | | 2018 |
| TGFâ upregulation mediates growth retardation in EGFR T790M mutant non-small cell lung cancer CE Repellin, PO Eser, M Capelletti, T Shimamura, D Ercan, C Xu, ... Cancer Research 76 (14_Supplement), 890-890, 2016 | | 2016 |
| Modulation of prostate cancer cell proliferation and gene expression by dietary fatty acids and effects of adipocyte conditioned media PO Eser | | 2012 |
